H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: AXSM) | Delayed: 166.00 -2.35 (1.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $168.35 | 52 Week High | $15.74 | |||
| Open | $169.50 | 52 Week Low | $5.37 | |||
| Day High | $170.80 | P/E | N/A | |||
| Day Low | $165.02 | EPS | $0.00 | |||
| Volume | 663,003 | |||||
